We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$49B
AUM Growth
+$3.53B
Cap. Flow
+$4.13B
Cap. Flow %
8.42%
Top 10 Hldgs %
10.78%
Holding
2,899
New
681
Increased
729
Reduced
681
Closed
701

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$290M
2
AMZN icon
Amazon
AMZN
+$287M
3
JCI icon
Johnson Controls International
JCI
+$275M
4
LHX icon
L3Harris
LHX
+$235M
5
V icon
Visa
V
+$235M

Sector Composition

Rank Sector Weight
1 Technology 12.75%
2 Industrials 11.17%
3 Healthcare 8.52%
4 Consumer Discretionary 7.23%
5 Financials 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBKR icon
2451
Interactive Brokers
IBKR
$42.5B
-1,776,348
Closed -$36.9M
IBRX icon
2452
ImmunityBio
IBRX
$8.26B
-193,285
Closed -$537K
ICLR icon
2453
Icon
ICLR
$13.3B
-60,757
Closed -$15.2M
IDCC icon
2454
InterDigital
IDCC
$8.84B
-13,574
Closed -$1.31M
IFF icon
2455
International Flavors & Fragrances
IFF
$21.5B
-22,906
Closed -$1.82M
IGIB icon
2456
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
-19,607
Closed -$992K
ILMN icon
2457
CALL
Illumina
ILMN
$33.1B
-133,640
Closed -$24.4M
IMAX icon
2458
IMAX
IMAX
$2.89B
-22,296
Closed -$379K
IMKTA icon
2459
Ingles Markets
IMKTA
$1.61B
-15,443
Closed -$1.28M
IMVT icon
2460
Immunovant
IMVT
$9.16B
-255,677
Closed -$5.78M
INFY icon
2461
PUT
Infosys
INFY
$48.4B
-375,000
Closed -$6.03M
INSG icon
2462
Inseego
INSG
$72.1M
-2,133
Closed -$13.7K
INSW icon
2463
International Seaways
INSW
$4.93B
-6,998
Closed -$268K
IONS icon
2464
Ionis Pharmaceuticals
IONS
$9.93B
-125,850
Closed -$5.16M
IQV icon
2465
IQVIA
IQV
$42.8B
-179,942
Closed -$40.4M
IRBT
2466
DELISTED
iRobot
IRBT
-58,435
Closed -$2.64M
IRBT
2467
PUT
DELISTED
iRobot
IRBT
-150,000
Closed -$6.79M
IT icon
2468
Gartner
IT
$12.4B
-390,039
Closed -$137M
ITB icon
2469
iShares US Home Construction ETF
ITB
$2.27B
-11,592
Closed -$990K
ITGR icon
2470
Integer Holdings
ITGR
$4.26B
-9,310
Closed -$825K
ITT icon
2471
ITT
ITT
$18.6B
-22,190
Closed -$2.07M
IVVD icon
2472
Invivyd
IVVD
$294M
-13,056
Closed -$13.7K
IVZ icon
2473
PUT
Invesco
IVZ
$14.1B
-560,000
Closed -$9.41M
JACK icon
2474
Jack in the Box
JACK
$331M
-187,046
Closed -$18.2M
JAKK icon
2475
Jakks Pacific
JAKK
$292M
-29,536
Closed -$590K

Similar funds

Dmitry Balyasny's Q3 2023 Portfolio in Review

As of Q3 2023, Dmitry Balyasny held 2,899 positions worth $49B, up 7.8% from $45.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Dmitry Balyasny deployed $4.13B of net new capital in Q3 2023, opening 681 new positions and adding to 729 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $290M trimmed.

  • Dmitry Balyasny's largest Q3 2023 buy was iShares Core S&P Small-Cap ETF: 2,405,092 shares worth $227M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $365M increase.
  • Dmitry Balyasny's biggest Q3 2023 reduction was McDonald's, cutting an estimated $290M.
  • Dmitry Balyasny fully exited Life Storage, Inc. in Q3 2023, selling an estimated $165M.
  • Dmitry Balyasny's ten largest holdings make up 11% of its $49B portfolio in Q3 2023.
  • Dmitry Balyasny opened 681 new positions and closed 701 in Q3 2023.
  • Dmitry Balyasny's portfolio value rose 7.8% quarter-over-quarter to $49B.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.